Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study

Yoshiya Tanaka, Tsutomu Takeuchi, Masato Okada, Tomonori Ishii, Hiroshi Nakajima, Shinichi Kawai, Takao Nagashima, Nobuya Hayashi, Liangwei Wang, Raj Tummala

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Fingerprint Dive into the research topics of 'Safety and tolerability of anifrolumab, a monoclonal antibody targeting type I interferon receptor, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences